Aviance Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Aviance Capital Partners's LLY Position: Q1 2026 in Review
Aviance Capital Partners increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $258K and bringing the position to 2,378 shares worth $2.19M. The position accounts for 0.26% of the portfolio, ranked #87.
Aviance Capital Partners first reported a position in LLY in Q2 2013 and has held it in 20 quarters since. The position peaked at $6.13M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Aviance Capital Partners held 2,378 shares of Eli Lilly worth $2.19M as of Q1 2026.
- Aviance Capital Partners bought 254 Eli Lilly shares in Q1 2026, an estimated $258K.
- Eli Lilly made up 0.26% of Aviance Capital Partners's portfolio in Q1 2026, its #87 holding.
- Aviance Capital Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 20 quarters since.
- Aviance Capital Partners's Eli Lilly position peaked at $6.13M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.